Accelerated evolution of resistance in multidrug environments
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
The emergence of resistance during multidrug chemotherapy impedes the treatment of many human diseases, including malaria, TB, HIV, and cancer. Although certain combination therapies have long been known to be more effective in curing patients than single drugs, the impact of such treatments on the evolution of drug resistance is unclear. In particular, very little is known about how the evolution of resistance is affected by the nature of the interactions—synergy or antagonism—between drugs. Here we directly measure the effect of various inhibitory and subinhibitory drug combinations on the rate of adaptation. We develop an automated assay for monitoring the parallel evolution of hundreds of Escherchia coli populations in a two-dimensional grid of drug gradients over many generations. We find a correlation between synergy and the rate of adaptation, whereby evolution in more synergistic drug combinations, typically preferred in clinical settings, is faster than evolution in antagonistic combinations. We also find that resistance to some synergistic combinations evolves faster than resistance to individual drugs. The accelerated evolution may be due to a larger selective advantage for resistance mutations in synergistic treatments. We describe a simple geometric model in which mutations conferring resistance to one drug of a synergistic pair prevent not only the inhibitory effect of that drug but also its enhancing effect on the other drug. Future study of the profound impact that synergy and other drug-pair properties can have on the rate of adaptation may suggest new treatment strategies for combating the spread of antibiotic resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the interactions can be highly dosedependent”
Citations
Cites
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517 · cited 2×
“To experimentally explore the relation between drug interaction and the rate of adaptation, we compared a drug pair that exhibits strong antagonism [doxycycline (DOX), a tetracycline antibiotic, and ciprofloxacin (CIP), a fluoroquinolone] to another pair showing strong synergy [DOX and a macrolide antibiotic, erythrom…”
BackgroundAntibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
The search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
Darwinian Evolution Can Follow Only Very Few Mutational Paths to Fitter Proteins
Weinreich, D. M., Delaney, N. F., DePristo, M. A., & Hartl, D. L. (2006) · Science · doi:10.1126/science.1123539 · Cited by 1,415
Self-citationBerenbaum, M. C. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00026-2 · Cited by 1,414
Evolution Experiments with Microorganisms: The Dynamics and Genetic Bases of Adaptation
Elena, S. F., & Lenski, R. E. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1088 · Cited by 1,386
Antibiotics: Actions, Origins, Resistance
Walsh, C. T. (2003) · Medical Entomology and Zoology · Cited by 675
Antibiotics: Actions, Origins, Resistance
Walsh, C. (2003) · Wiley eBooks · doi:10.1128/9781555817886 · Cited by 633
Lack of development of new antimicrobial drugs: a potential serious threat to public health
Norrby, S. R., Nord, C. E., & Finch, R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)01283-1 · Cited by 491
Research works printed but not linked: 1
- 10.1016/s1473-3099(05)70086-4 · doi:10.1016/s1473-3099(05)70086-4 · Paper page
Cited by
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced Mutagenesis
Kohanski, M. A., DePristo, M. A., & Collins, J. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.003 · Cited by 985
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 820
Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria
Morones-Ramirez, J. R., Winkler, J. A., Spina, C. S., & Collins, J. J. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006276 · Cited by 756
Multidrug evolutionary strategies to reverse antibiotic resistance
Baym, M., Stone, L. K., & Kishony, R. (2016) · Science · doi:10.1126/science.aad3292 · Cited by 710
Self-citationStokes, H. W., & Gillings, M. R. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00273.x · Cited by 619
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., Mohsen, Y., Adukkadukkam, S., Awuah, W. A., Jose, R. A. M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11020200 · Cited by 567
Spatiotemporal microbial evolution on antibiotic landscapes
Baym, M., Lieberman, T. D., Kelsic, E. D., Chait, R., Gross, R., Yelin, I., & Kishony, R. (2016) · Science · doi:10.1126/science.aag0822 · Cited by 538
Self-citationPotentiating antibacterial activity by predictably enhancing endogenous microbial ROS production
Brynildsen, M. P., Winkler, J. A., Spina, C. S., MacDonald, I. C., & Collins, J. J. (2013) · Nature Biotechnology · doi:10.1038/nbt.2458 · Cited by 470
Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Romero-Canelón, I., & Sadler, P. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400835n · Cited by 396
Therapeutic strategies to combat antibiotic resistance
Brooks, B. D., & Brooks, A. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.027 · Cited by 367
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
Drug interactions and the evolution of antibiotic resistance
Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2133 · Cited by 350
“Recent studies have suggested that antagonistic drug pairs can slow down and potentially even reverse the evolution of drug resistanc”
Self-citationBacterial evolution of antibiotic hypersensitivity
Lázár, V., Pal Singh, G., Spohn, R., Nagy, I., Horváth, B., Hrtyan, M., Busa‐Fekete, R., Bogos, B., Méhi, O., Csörgő, B., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.57 · Cited by 350
Scalable, Continuous Evolution of Genes at Mutation Rates above Genomic Error Thresholds
Ravikumar, A., Arzumanyan, G. A., Obadi, M. K. A., Javanpour, A. A., & Liu, C. C. (2018) · Cell · doi:10.1016/j.cell.2018.10.021 · Cited by 300
Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance
Palmer, A. C., & Kishony, R. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3351 · Cited by 285
Self-citationAntagonism between Bacteriostatic and Bactericidal Antibiotics Is Prevalent
Ocampo, P. S., Lázár, V., Papp, B., Arnoldini, M., Abel zur Wiesch, P., Busa-Fekete, R., Fekete, G., Pál, C., Ackermann, M., & Bonhoeffer, S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02463-14 · Cited by 284
Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance
Kim, S., Lieberman, T. D., & Kishony, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409800111 · Cited by 264
Self-citationAntimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution
Bollenbach, T. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.05.008 · Cited by 261
Combination therapies for combating antimicrobial resistance
Fischbach, M. A. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.08.003 · Cited by 259
Positive Epistasis Drives the Acquisition of Multidrug Resistance
Trindade, S., Sousa, A., Xavier, K. B., Dionisio, F., Ferreira, M. G., & Gordo, I. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000578 · Cited by 252
MacLean, R. C., Hall, A. R., Perron, G. G., & Buckling, A. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2778 · Cited by 247
Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms
Hughes, D., & Andersson, D. I. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3922 · Cited by 245
Heterogeneity of selection and the evolution of resistance
(2013) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2012.09.001 · Cited by 240
Rapid screening of antibiotic toxicity in an automated microdroplet system
Churski, K., Kaminski, T. S., Jakiela, S., Kamysz, W., Baranska-Rybak, W., Weibel, D. B., & Garstecki, P. (2012) · Lab on a Chip · doi:10.1039/c2lc21284f · Cited by 228
Nonoptimal microbial response to antibiotics underlies suppressive drug interactions
Bollenbach, T., Quan, S., Chait, R., & Kishony, R. (2009) · Cell · doi:10.1016/j.cell.2009.10.025 · Cited by 227
Self-citationPena-Miller, R., Laehnemann, D., Jansen, G., Fuentes-Hernandez, A., Rosenstiel, P., Schulenburg, H., & Beardmore, R. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001540 · Cited by 209
Toprak, E., Veres, A., Yildiz, S., Pedraza, J. M., Chait, R., Paulsson, J., & Kishony, R. (2013) · Nature Protocols · doi:10.1038/nprot.nprot.2013.021 · Cited by 186
Self-citationChen, X., Zhang, Q., Li, J., Yang, M., Zhao, N., & Xu, F.-J. (2018) · ACS Nano · doi:10.1021/acsnano.8b01440 · Cited by 186
Experimental Design, Population Dynamics, and Diversity in Microbial Experimental Evolution
Van den Bergh, B., Swings, T., Fauvart, M., & Michiels, J. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00008-18 · Cited by 180
Multitarget Approaches against Multiresistant Superbugs
Gray, D. A., & Wenzel, M. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00001 · Cited by 179
Munck, C., Gumpert, H. K., Wallin, A. I. N., Wang, H. H., & Sommer, M. O. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009940 · Cited by 178
Padilla-Cruz, A. L., Garza-Cervantes, J. A., Vasto-Anzaldo, X. G., García-Rivas, G., León-Buitimea, A., & Morones-Ramírez, J. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-84768-8 · Cited by 178
Liu, Z., Guo, K., Yan, L., Zhang, K., Wang, Y., Ding, X., Zhao, N., & Xu, F.-J. (2023) · Nature Communications · doi:10.1038/s41467-023-40830-9 · Cited by 166
Torres-Barceló, C., Arias-Sánchez, F. I., Vasse, M., Ramsayer, J., Kaltz, O., & Hochberg, M. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106628 · Cited by 166
Alternative Evolutionary Paths to Bacterial Antibiotic Resistance Cause Distinct Collateral Effects
Barbosa, C., Trebosc, V., Kemmer, C., Rosenstiel, P., Beardmore, R., Schulenburg, H., & Jansen, G. (2017) · Molecular Biology and Evolution · doi:10.1093/molbev/msx158 · Cited by 165
Optimal Drug Synergy in Antimicrobial Treatments
Torella, J. P., Chait, R., & Kishony, R. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000796 · Cited by 162
Self-citationQiao, Z., Zhang, K., Liu, J., Cheng, D., Yu, B., Zhao, N., & Xu, F. (2022) · Nature Communications · doi:10.1038/s41467-022-34883-5 · Cited by 163
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA
Gonzales, P. R., Pesesky, M. W., Bouley, R., Ballard, A., Biddy, B. A., Suckow, M. A., Wolter, W. R., Schroeder, V. A., Burnham, C.-A. D., Mobashery, S., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1911 · Cited by 160
The Genomic Enzymology of Antibiotic Resistance
Morar, M., & Wright, G. D. (2010) · Annual Review of Genetics · doi:10.1146/annurev-genet-102209-163517 · Cited by 147
Jochumsen, N., Marvig, R. L., Damkiær, S., Jensen, R. L., Paulander, W., Molin, S., Jelsbak, L., & Folkesson, A. (2016) · Nature Communications · doi:10.1038/ncomms13002 · Cited by 147
Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance
Pokrovskaya, V., & Baasov, T. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.508069 · Cited by 146
Courtney, C. M., Goodman, S. M., Nagy, T. A., Levy, M., Bhusal, P., Madinger, N. E., Detweiler, C. S., Nagpal, P., & Chatterjee, A. (2017) · Science Advances · doi:10.1126/sciadv.1701776 · Cited by 140
Dai, X., Zhao, X., Liu, Y., Chen, B., Ding, X., Zhao, N., & Xu, F. (2021) · Small · doi:10.1002/smll.202006004 · Cited by 139
The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy
Trauner, A., Liu, Q., Via, L. E., Liu, X., Ruan, X., Liang, L., Shi, H., Chen, Y., Wang, Z., Liang, R., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1196-0 · Cited by 138
Better together– Salmonella biofilm-associated antibiotic resistance
Aleksandrowicz, A., Carolak, E., Dutkiewicz, A., Błachut, A., Waszczuk, W., & Grzymajło, K. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2229937 · Cited by 139
Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms
Habash, M. B., Park, A. J., Vis, E. C., Harris, R. J., & Khursigara, C. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03170-14 · Cited by 134
How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient
Hansen, E., Woods, R. J., & Read, A. F. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2001110 · Cited by 132
Maltas, J., & Wood, K. B. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000515 · Cited by 129
Raymond, B. (2019) · Evolutionary Applications · doi:10.1111/eva.12808 · Cited by 126
Rezzoagli, C., Archetti, M., Mignot, I., Baumgartner, M., & Kümmerli, R. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000805 · Cited by 126
Epistasis and the Evolution of Antimicrobial Resistance
Wong, A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00246 · Cited by 125
Evolutionary rescue: linking theory for conservation and medicine
Alexander, H. K., Martin, G., Martin, O. Y., & Bonhoeffer, S. (2014) · Evolutionary Applications · doi:10.1111/eva.12221 · Cited by 123
de Evgrafov, M. C. R., Gumpert, H., Munck, C., Thomsen, T. T., & Sommer, M. O. A. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv006 · Cited by 121
Synergistic Antimicrobial Effects of Silver/Transition-metal Combinatorial Treatments
Garza-Cervantes, J. A., Chávez‐Reyes, A., Castillo, E. C., García‐Rivas, G., Ortega-Rivera, O. A., Salinas, E., Ortiz‐Martínez, M., Gómez-Flores, S. L., Peña-Martínez, J. A., Pepi-Molina, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01017-7 · Cited by 116
Jahn, L. J., Munck, C., Ellabaan, M. M. H., & Sommer, M. O. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00816 · Cited by 114
Combination therapeutics in complex diseases
He, B., Lu, C., Zheng, G., He, X., Wang, M., Chen, G., Zhang, G., & Lu, A. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12930 · Cited by 112
Intratumor heterogeneity alters most effective drugs in designed combinations
Zhao, B., Hemann, M. T., & Lauffenburger, D. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323934111 · Cited by 111
Janga, S. C., & Tzakos, A. G. (2009) · Molecular BioSystems · doi:10.1039/b908147j · Cited by 110
Suppressive drug combinations and their potential to combat antibiotic resistance
Singh, N. P., & Yeh, P. J. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.102 · Cited by 107
Geilich, B., van de Ven, A. L., Singleton, G. L., Sepúlveda, L. J., Sridhar, S., & Webster, T. J. (2015) · Nanoscale · doi:10.1039/c4nr05823b · Cited by 101
Is selection relevant in the evolutionary emergence of drug resistance?
Day, T., Huijben, S., & Read, A. F. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.01.005 · Cited by 99
Lagator, M., Vogwill, T., Mead, A., Colegrave, N., & Neve, P. (2013) · New Phytologist · doi:10.1111/nph.12195 · Cited by 98
Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis
Lee, B. S., Hards, K., Engelhart, C. A., Hasenoehrl, E. J., Kalia, N. P., Mackenzie, J. S., Sviriaeva, E., Chong, S. M. S., Manimekalai, M. S. S., Koh, V. H., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013207 · Cited by 97
HSP90 as a platform for the assembly of more effective cancer chemotherapy
Whitesell, L. J., & Lin, N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.12.006 · Cited by 95
Barbosa, C., Roemhild, R., Rosenstiel, P. C., & Schulenburg, H. (2019) · eLife · doi:10.7554/elife.51481 · Cited by 94
Cellular hysteresis as a principle to maximize the efficacy of antibiotic therapy
Roemhild, R., Gokhale, C. S., Dirksen, P., Blake, C., Rosenstiel, P. C., Traulsen, A., Andersson, D. I., & Schulenburg, H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810004115 · Cited by 94
Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations
Hill, J. A., Ammar, R., Torti, D., Nislow, C., & Cowen, L. E. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003390 · Cited by 93
Atif, M., Azeem, M., Saqib, A., & Scahill, S. L. (2017) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-017-0199-7 · Cited by 92
Merker, M., Tüeffers, L., Vallier, M., Groth, E. E., Sonnenkalb, L., Unterweger, D., Baines, J. F., Niemann, S., & Schulenburg, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01938 · Cited by 93
Aggressive Chemotherapy and the Selection of Drug Resistant Pathogens
Huijben, S., Bell, A. S., Sim, D. G., Tomasello, D. L., Mideo, N., Day, T., & Read, A. F. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003578 · Cited by 91
Antibiotic combination efficacy (ACE) networks for a Pseudomonas aeruginosa model
Barbosa, C., Beardmore, R., Schulenburg, H., & Jansen, G. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2004356 · Cited by 91
Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy
Ayhan, D. H., Tamer, Y. T., Akbar, M. A., Bailey, S. M., Wong, M., Daly, S. M., Greenberg, D. E., & Toprak, E. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002552 · Cited by 90
Insect Antimicrobial Peptide Complexes Prevent Resistance Development in Bacteria
Chernysh, S. I., Gordya, N. A., & Николаевна, С. Т. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130788 · Cited by 89
Evolutionary stability of antibiotic protection in a defensive symbiosis
Engl, T., Kroiß, J., Kai, M., Nechitaylo, T. Y., Svatoš, A., & Kaltenpoth, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719797115 · Cited by 89
Zhitnitsky, D., Rose, J., & Lewinson, O. (2017) · Scientific Reports · doi:10.1038/srep44554 · Cited by 88
Systematic discovery of drug interaction mechanisms
Chevereau, G., & Bollenbach, T. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156098 · Cited by 88
Highly parallel lab evolution reveals that epistasis can curb the evolution of antibiotic resistance
Lukačišinová, M., Fernando, B., & Bollenbach, T. (2020) · Nature Communications · doi:10.1038/s41467-020-16932-z · Cited by 85
Yang, Y., Yu, Y., Li, X., Li, J., Wu, Y., Yu, J., Ge, J., Huang, Z., Jiang, L., Rao, Y., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01733 · Cited by 86
Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms
Habash, M., Goodyear, M. C., Park, A. J., Surette, M. D., Vis, E. C., Harris, R. J., & Khursigara, C. M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00415-17 · Cited by 84
Saputra, E. C., Huang, L., Chen, Y., & Tucker‐Kellogg, L. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1201 · Cited by 83
Mohan, A., Padiadpu, J., Baloni, P., & Chandra, N. R. (2015) · Genome Announcements · doi:10.1128/genomea.01520-14 · Cited by 82
Using a Sequential Regimen to Eliminate Bacteria at Sublethal Antibiotic Dosages
Fuentes-Hernandez, A., Plucain, J., Gori, F., Pena-Miller, R., Reding, C., Jansen, G., Schulenburg, H., Gudelj, I., & Beardmore, R. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002104 · Cited by 82
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application
Calzetta, L., Page, C. P., Matera, M. G., Cazzola, M., & Rogliani, P. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000951 · Cited by 82
Drug combinations targeting antibiotic resistance
Bognár, B., Spohn, R., & Lázár, V. (2024) · npj Antimicrobials and Resistance · doi:10.1038/s44259-024-00047-2 · Cited by 83
Ho, Y.-H., SHAH, P. M., Chen, Y.-W., & Chen, C. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.054999 · Cited by 82
Karslake, J., Maltas, J., Brumm, P., & Wood, K. B. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005098 · Cited by 77
Using Combination Therapy to Thwart Drug Resistance
Hill, J. A., & Cowen, L. E. (2015) · Future Microbiology · doi:10.2217/fmb.15.68 · Cited by 75
The Role of Recombination in Evolutionary Rescue
Uecker, H., & Hermisson, J. (2015) · Genetics · doi:10.1534/genetics.115.180299 · Cited by 74
Yan, H., Zhang, B., Li, S., & Zhao, Q. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-50 · Cited by 73
The Yin and Yang of Bacterial Resilience in the Human Gut Microbiota
Gibson, M. K., Pesesky, M. W., & Dantas, G. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.05.029 · Cited by 71
Additivity of inhibitory effects in multidrug combinations
Russ, D., & Kishony, R. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0252-1 · Cited by 71
Self-citationTekin, E., Beppler, C., White, C., Mao, Z., Savage, V. M., & Yeh, P. J. (2016) · Journal of The Royal Society Interface · doi:10.1098/rsif.2016.0332 · Cited by 71
De Novo Acquisition of Resistance to Three Antibiotics by Escherichia coli
van der Horst, M. A., Schuurmans, J. M., Smid, M. C., Koenders, B. B., & ter Kuile, B. H. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2010.0101 · Cited by 68
Combating antimicrobial resistance: the silent war
Bo, L., Sun, H., Li, Y.-D., Zhu, J. J., Wurpel, J. N. D., Lin, H., & Chen, Z. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1347750 · Cited by 68
Roemhild, R., Barbosa, C., Beardmore, R., Jansen, G., & Schulenburg, H. (2015) · Evolutionary Applications · doi:10.1111/eva.12330 · Cited by 67
Experimental evolution as an efficient tool to dissect adaptive paths to antibiotic resistance
Jansen, G., Barbosa, C., & Schulenburg, H. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2014.02.002 · Cited by 66
Brief antibiotic use drives human gut bacteria towards low-cost resistance
Yaffe, E., Dethlefsen, L., Patankar, A. V., Gui, C., Holmes, S., & Relman, D. A. (2025) · Nature · doi:10.1038/s41586-025-08781-x · Cited by 65
Metadata
- Authors
- Hegreness, M., Shoresh, N., Damian, D., Hartl, D., & Kishony, R.
- Affiliations
- Harvard University (US)
- *Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115;
- Vertex Pharmaceuticals (United States) (US)
- Department of Organismic and Evolutionary Biology and
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-16
- Volume
- 105
- Issue
- 37
- Pages
- 13977-13981
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2544564
- OpenAlex
- W2080777238
- Cited by
- 300
- References
- 33
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 23 · 2023: 26 · 2022: 12 · 2021: 21 · 2020: 18 · 2019: 20 · 2018: 12 · 2017: 28 · 2016: 18 · 2015: 21 · 2014: 18 · 2013: 21 · 2012: 7
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM081617)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- drug resistance evolution, multidrug chemotherapy, drug synergy, drug antagonism, combination therapy, rate of adaptation, Escherichia coli, parallel evolution, antibiotic resistance, resistance mutations
- MeSH terms
- Adaptation, Biological, Biological Evolution, Drug Resistance, Multiple
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.